• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-160
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/25/2024
Event Type  malfunction  
Event Description
The consumer reported accidental reagent exposure to her eye with a binaxnow covid-19 antigen self-test on (b)(6) 2024.Per the consumer, she accidentally spilled some of the drops of the reagent liquid into her eyes.The consumer confirmed she was not having any irritation or burning sensation, but it was a little bit itchy.Consumer did not require any further medical intervention and there was no reported patient impact.The consumer confirmed there was no death or serious injury.No additional information was provided.
 
Manufacturer Narrative
Fda udi (b)(4).The remainder of the investigation remains in progress.A supplemental report will be provided after completion.Single use; device discarded.
 
Event Description
The consumer reported accidental reagent exposure to her eye with a binaxnow covid-19 antigen self-test on (b)(6) 2024.Per the consumer, she accidentally spilled some of the drops of the reagent liquid into her eyes.The consumer confirmed she was not having any irritation or burning sensation, but it was a little bit itchy.Consumer did not require any further medical intervention and there was no reported patient impact.The consumer confirmed there was no death or serious injury.No additional information was provided.
 
Manufacturer Narrative
Fda udi - (b)(4).A product deficiency was not reported or found.Technical services advised the consumer to contact their health provider if any irritation occurred.Technical services was unable to send the consumer the reagent safety data sheet as the consumer did not provide any other contact information.The reported health status is anticipated in nature and severity for binaxnow covid-19 ag card risk documentation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 2CT
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key18922092
MDR Text Key337881390
Report Number1221359-2024-00273
Device Sequence Number1
Product Code QKP
UDI-Device Identifier00811877011408
UDI-Public01008118770114081724100510235437
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 04/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number195-160
Device Lot Number235437
Was Device Available for Evaluation? No
Date Manufacturer Received04/09/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age59 YR
Patient SexFemale
Patient Weight68 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-